Literature DB >> 20103035

Are you compliant with addressing glaucoma adherence?

Steven L Mansberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20103035      PMCID： PMC2813198          DOI： 10.1016/j.ajo.2009.08.011

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  13 in total

Review 1.  Interventions to enhance patient adherence to medication prescriptions: scientific review.

Authors:  Heather P McDonald; Amit X Garg; R Brian Haynes
Journal:  JAMA       Date:  2002-12-11       Impact factor: 56.272

2.  Compliance with topical pilocarpine treatment.

Authors:  M A Kass; D W Meltzer; M Gordon; D Cooper; J Goldberg
Journal:  Am J Ophthalmol       Date:  1986-05-15       Impact factor: 5.258

3.  Early Manifest Glaucoma Trial: design and baseline data.

Authors:  M C Leske; A Heijl; L Hyman; B Bengtsson
Journal:  Ophthalmology       Date:  1999-11       Impact factor: 12.079

4.  Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study.

Authors:  David C Herman; Mae O Gordon; Julia A Beiser; Leo T Chylack; Kathleen A Lamping; Oliver D Schein; Joern B Soltau; Michael A Kass
Journal:  Am J Ophthalmol       Date:  2006-11       Impact factor: 5.258

5.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

6.  The economic burden of major adult visual disorders in the United States.

Authors:  David B Rein; Ping Zhang; Kathleen E Wirth; Paul P Lee; Thomas J Hoerger; Nancy McCall; Ronald Klein; James M Tielsch; Sandeep Vijan; Jinan Saaddine
Journal:  Arch Ophthalmol       Date:  2006-12

7.  Glaucoma management among individuals enrolled in a single comprehensive insurance plan.

Authors:  David S Friedman; Beth Nordstrom; Essy Mozaffari; Harry A Quigley
Journal:  Ophthalmology       Date:  2005-09       Impact factor: 12.079

8.  Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.

Authors:  Constance O Okeke; Harry A Quigley; Henry D Jampel; Gui-shuang Ying; Ryan J Plyler; Yuzhen Jiang; David S Friedman
Journal:  Ophthalmology       Date:  2008-12-12       Impact factor: 12.079

9.  Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?

Authors:  M A Kass; M Gordon; D W Meltzer
Journal:  Am J Ophthalmol       Date:  1986-05-15       Impact factor: 5.258

10.  Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.

Authors:  Alan L Robin; Gary D Novack; David W Covert; R Stephens Crockett; Tania S Marcic
Journal:  Am J Ophthalmol       Date:  2007-08-08       Impact factor: 5.258
View more
  5 in total

1.  A novel EyePhone© App for improving adherence to glaucoma therapy.

Authors:  Ari Leshno; Dan Gaton; Reut Singer; Elior Eliasi; Ofri Vorobichik-Berar; Shiran Madgar; Ori Stern; Wasim Jaber; Noa Kapelushnik; Alon Skaat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-02       Impact factor: 3.117

2.  Predictors of adherence to glaucoma treatment in a multisite study.

Authors:  Paul F Cook; Sarah J Schmiege; Steven L Mansberger; Jeffrey Kammer; Timothy Fitzgerald; Malik Y Kahook
Journal:  Ann Behav Med       Date:  2015-02

3.  Adherence to topical glaucoma medications in Ethiopian patients.

Authors:  Lemlem Tamrat; Girum W Gessesse; Yeshigeta Gelaw
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar

4.  Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool.

Authors:  Facundo G Sanchez; Steven L Mansberger; Paula A Newman-Casey
Journal:  J Glaucoma       Date:  2020-11       Impact factor: 2.290

5.  Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months.

Authors:  Steven D Vold; Lilit Voskanyan; Manfred Tetz; Gerd Auffarth; Imran Masood; Leon Au; Iqbal Ike K Ahmed; Hady Saheb
Journal:  Ophthalmol Ther       Date:  2016-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.